These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10909502)

  • 1. [Acute liver damage after using ecstasy].
    Shiloach E; Zecler E; Horowiz M; Scapa E
    Harefuah; 1998 Feb; 134(4):266-9, 335. PubMed ID: 10909502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Painless jaundice after ecstasy and alcohol consumption].
    Kis L; Pfaffenberger M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1035-7. PubMed ID: 17639967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute giant cell hepatitis in a 17-year old man].
    Muñoz P; Drobinska A; Bianchi L; Züger Ch; Pirovino M
    Praxis (Bern 1994); 2004 Dec; 93(50):2109-12. PubMed ID: 15646679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.
    Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V
    Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis and Ecstasy].
    Pascual Bartolomé S; Sarrión Martínez JV; García Herola A; Berenguer Lapuerta J
    Med Clin (Barc); 1997 Feb; 108(7):279. PubMed ID: 9121201
    [No Abstract]   [Full Text] [Related]  

  • 6. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute hepatitis induced by Ecstasy].
    Indart Pérez A; Mendia Gorostidi A; Barrio Andrés J; Arens Miravé I
    Gastroenterol Hepatol; 1998 Dec; 21(10):499. PubMed ID: 9927798
    [No Abstract]   [Full Text] [Related]  

  • 10. Ecstasy-induced acute coronary syndrome: something to rave about.
    Hoggett K; McCoubrie D; Fatovich DM
    Emerg Med Australas; 2012 Jun; 24(3):339-42. PubMed ID: 22672176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
    Khakoo SI; Coles CJ; Armstrong JS; Barry RE
    J Clin Gastroenterol; 1995 Apr; 20(3):244-7. PubMed ID: 7797836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the hepatotoxic effects of ecstasy.
    Carvalho M; Pontes H; Remião F; Bastos ML; Carvalho F
    Curr Pharm Biotechnol; 2010 Aug; 11(5):476-95. PubMed ID: 20420570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Death after the intake of amphetamine/ecstasy: two case reports].
    Wöllner K; Stockhausen S; Mußhoff F; Madea B
    Arch Kriminol; 2015; 235(1-2):53-61. PubMed ID: 26419092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
    Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
    Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Ecstasy"-induced hepatitis in an active duty soldier.
    Hwang I; Daniels AM; Holtzmuller KC
    Mil Med; 2002 Feb; 167(2):155-6. PubMed ID: 11873540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XTC-induced hepatitis.
    Oranje WA; von Pol P; vd Wurff A; Zeijen RN; Stockbrügger RW; Arends JW
    Neth J Med; 1994 Feb; 44(2):56-9. PubMed ID: 7911561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.